Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer

By Bolton D.   Ta A.   Bagnato M.   Muller D.   Lawrentschuk N.   Severi G.   Syme R.   Giles G.  

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 431-435

Springer Publishing Company

Access to resources Recommend Favorite

The Impact of Prostate Volume Following Neoadjuvant Androgen Deprivation on Quality of Life and Voiding Symptoms in Patients Undergoing Permanent Prostate Brachytherapy

By Krupski T.   Bissonette E.A.   Petroni G.R.   Theodorescu D.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 467-472

Elsevier

Access to resources Recommend Favorite

Do prostate cancers in younger men have worse pathological characteristics in the PSA era?

By Foley C.L.   Bott S.R.J.   Parkinson M.C.   Kirby R.S.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 7-7

Elsevier

Access to resources Recommend Favorite

Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings

By Ruska K.M.   Partin A.W.   Epstein J.I.   Kahane H.  

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1179-1183

Elsevier

Access to resources Recommend Favorite

Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?

By Aaltomaa Sirpa H.   Kataja Vesa V.   Räty Atte   Palmgren Jan-Erik   Lahtinen Tapani  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 5, 2011-11 ,pp. : 339-345

Informa Healthcare

Access to resources Recommend Favorite